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Abstract
Inhalation of Aspergillus fumigatus conidia can cause severe aspergillosis in immunosuppressed people. A. fumigatus
produces a large number of secondary metabolites, some of which are airborne by conidia and whose toxicity to the
respiratory tract has not been investigated. We found that spores of A. fumigatus contain five main compounds,
tryptoquivaline F, fumiquinazoline C, questin, monomethylsulochrin and trypacidin. Fractionation of culture extracts using
RP-HPLC and LC-MS showed that samples containing questin, monomethylsulochrin and trypacidin were toxic to the
human A549 lung cell line. These compounds were purified and their structure verified using NMR in order to compare their
toxicity against A549 cells. Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects
occurring at an IC50 close to 7 mM. Trypacidin toxicity was also observed in the same concentration range on human
bronchial epithelial cells. In the first hour of exposure, trypacidin initiates the intracellular formation of nitric oxide (NO) and
hydrogen peroxide (H2O2). This oxidative stress triggers necrotic cell death in the following 24 h. The apoptosis pathway,
moreover, was not involved in the cell death process as trypacidin did not induce apoptotic bodies or a decrease in
mitochondrial membrane potential. This is the first time that the toxicity of trypacidin to lung cells has been reported.
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Introduction
For over twenty years, Aspergillus fumigatus has been considered
as the most common airborne fungal pathogen. It is a saprophytic
fungus that can grow outdoors on different organic materials
including cereals, malted barley, packed hay, compost and
tobacco. Growth indoors has been reported using water-damaged
building materials [1], old paper [2] and damp wallpaper [3] as
substrates. Exposure to inhaled A. fumigatus spores is, therefore,
likely common throughout life. The size of such spores (2 to 3 mm
in diameter) allows them to travel easily through the respiratory
tract and into lung alveoli. The spores are commonly found in the
environment and can exceed 10
4 spores/m
3 in damp buildings or
even 10 to 100 times more in waste or compost handling facilities
[4]. More than a hundred genotypes of A. fumigatus can be present
in hospital buildings [5]. This fungus causes different pathologies
including occupational rhinitis in people working in damp and
mouldy places [6], allergic aspergillosis and invasive forms of
aspergillosis in immunosuppressed patients [7]. Several cases of
acute pulmonary aspergillosis in immunocompetent patients have
been reported [8,9,10]. The factors that enable A. fumigatus to
cause invasive disease are not currently understood [11].
Previous studies had identified the presence of 26 gene clusters
in the A. fumigatus genome putatively involved in secondary
metabolism [12,13]. Using the Smurf software, we could update
the number of clusters to 28 and 30 for A1193 and Af293 strain
respectively. These data suggest a major production of secondary
metabolites by A. fumigatus [14]. The chemical structures of a large
number of metabolites are well characterized including the well-
known gliotoxin [15], which has multiple cytotoxic and immuno-
suppressive properties [11]. Gliotoxin is the only toxin isolated
from the sera of rodents and of patients suffering from invasive
aspergillosis [16]. The contribution of gliotoxin in vivo was
characterized by disrupting either the gene encoding the non-
ribosomal peptide synthase gliP or the gene encoding the
transcriptional factor gliZ, both of which are indispensable to
gliotoxin biosynthesis. The decrease in virulence of mutant strains,
however, has only been demonstrated in non-neutropenic mice
suggesting that gliotoxin plays an important role in the
pathogenesis in immunosuppressed but not neutropenic patients
[17]. The use of HPLC and TLC, furthermore, failed to detect
gliotoxin in spores [18], while it is well known that gliotoxin is
produced by the fungus once it is growing within the target tissue
[7,11].
Although the gliotoxin toxicity and its putative involvement in
A. fumigatus mycoses have been well documented, few data
regarding the potential toxicity of other metabolites present on
the conidia are available. Fumigaclavine C and three other minor
ergot alkaloids, festuclavine, fumigaclavine A and fumigaclavine B
have also been shown to be associated with A. fumigatus conidia
[19]. It has been shown that conidia from A. fumigatus grown on
different media bear other metabolites including trypacidin,
tryptoquivaline, fumitremorgin A [20]. Moreover, only trypacidin
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compost facilities containing 3.2610
7 A. fumigatus spores/m
3 [21].
Trypacidin and monomethylsulochrin were isolated from A.
fumigatus at the beginning of the 1960 s [22,23]. The antibiotic
and antiprotozoal properties of trypacidin were described in 1963
[22] and the chemical structure was identified in 1965 [24]. No
attempt has been made so far to evaluate the toxicity of these
metabolites on the respiratory tract.
The objectives of the present study were, therefore, to evaluate
the toxicity of the metabolites borne by the spores of A. fumigatus
and to determine the cytotoxic effects they induce in lung cells.
Materials and Methods
Chemicals
Gliotoxin, verruculogen, fumagillin and helvolic acid were
purchased from Sigma-Aldrich (Saint Quentin Fallavier, France),
fumitremorgin C, pseurotin A and fumigaclavine A from Alexis
Biochemicals (Enzo Life sciences, Farmingdale, NY), sulochrin
from BioAustralis Fine Chemicals (Smithfield, Australia). All
commercial products were used without further purification
(purities higher than 90%). The sources of the other secondary
metabolites used as authentic standards were: J.W Dorner,
National Peanut Research Laboratory, ARS-USDA, Dawson,
USA (fumigaclavine C), C. Avendano, Universidad Complutense,
Madrid, Spain (fumiquinazoline F), and P.G. Mantle, Imperial
College, London, UK (TR2 toxin). All solvents used in extraction,
flash chromatography, liquid chromatography-diode array detec-
tor (LC-DAD) and liquid chromatography-mass spectrometry
(LC-MS) were analytical grade. Water for high performance liquid
chromatography was purified by using a Millipore MilliQ
purification system.
Metabolite extraction from conidia
Large amounts of conidia from Aspergillus fumigatus NRRL 35693
strain were produced on Czapek yeast extract agar (CYA) and
potato dextrose agar (PDA) medium for 14 days at 37uC in the
dark. Ten 90 mm plates were prepared for each culture medium.
The conidia were harvested as described previously [25]. Then,
the conidia solution was filtered through a porosity 2 filter funnel
(Robu, Hattert, Germany) following a second filtration through
Miracloth (Merck Chemicals, Darmstadt, Germany) to remove
hyphae. The absence of mycelium was checked by optical
microscopy.
Fungal strain culture conditions
Fifteen other fungal strains of A. fumigatus from the Pharmacol-
ogy-Toxicology Laboratory New Collection (NCPT) were exam-
ined for their ability to produce trypacidin (Table S1). The strains
were selected from various human, animal, plant and environ-
mental sources and geographical regions. In order to determine
which mycotoxins are associated with conidiogenesis, we com-
pared HPLC-DAD and MS analyses of culture extracts from the
conidiation-deficient A. fumigatus strain (DbrlA) vs the conidiation-
restored strain (DbrlA::brlA). The generation and morphological
characterization of both strains have been described previously
[26]. The strains were grown on PDA for 8 days at 25uC and the
cultures then extracted with 70 ml chloroform. After filtration
through Whatman SP filters, the organic phase was evaporated
under vacuum at 50uC using a rotary evaporator. The residue was
taken up in 200 ml of methanol and this suspension filtered
through a 0.45 mm disposable filter before HPLC analysis.
Trypacidin production by A. fumigatus strains was measured after
culture on autoclaved grains of CapHorn, a variety of common
wheat. Wheat grains were moistened with sterile distilled water for
4 days at 4uC (to reach a water activity aW of 0.98) before 20 min
sterilization at 120uC. Thirty grams were placed into a 140 mm
diameter petri dish and inoculated with 250 ml of a spore
suspension containing 2610
5 conidia, obtained from a preliminary
culture on PDA medium at 37uC for 7 days. The cultures on the
grains were incubated at 25uC for 13 days. The A. fumigatus
NRRL35693 (NCPT13) strain was used to identify the toxic
metabolites produced by the fungus and to produce and purify
trypacidin, monomethylsulochrin and questin.
HPLC-MS and MS-MS analysis of fractions
Chromatographic analyses were performed on a Thermo-
Finnigan surveyor HPLC system with a diode array detector
(DAD) and a LCQ XP MAXH ion trap mass spectrometer
(Thermo Electron Corporation, Waltham, MA). The LC separa-
tion was accomplished with a 150 mm62.1 mm Luna 5 mm C18
column (Phenomenex, Torrance, CA). A gradient elution was used
at a flow rate of 0.2 ml/min with a mobile phase of 16.6 mM
acetic acid (A) and acetonitrile (B) under the following conditions:
the program initiated with 80/20% (v/v) eluent A/B for 5 min,
then eluent B was increased to 50% (v/v) over 25 min, and to 90%
(v/v) over 5 min, held constant at 90% (v/v) for 10 min, then
finally returned to the initial 20% (v/v) and kept at this level for
the last 10 min. Molecules were ionized with an electrospray
ionization source in negative (ESI2) and positive mode (ESI+).
For the negative mode, the spray needle was set at a potential of
4.5 kV. Capillary voltage and temperature were 215 V and
375uC respectively. For the positive mode, the source voltage was
increased to 5 kV whereas capillary voltage was set to 3 V. The
capillary temperature remained unchanged. For both modes,
sheath gas and auxiliary gas flow rate of nitrogen were at 70 and
40 (arbitrary units). The tube lens offsets were set for negative and
positive mode to 245 V and 5 V respectively. Helium was used in
the trap as the damping and collision gas. Culture and fraction
extracts were analysed in full scan and MS/MS mode with a m/z
range of 50 to 800. MS and MS-MS tuning were performed on
authentic fumigaclavine C and the MS-MS collision was set at
40%.
Fractionation of culture extracts
After extraction of secondary metabolites with chloroform, the
raw extract was fractioned by an automated flash chromatography
instrument (Teledyne Isco, Lincoln, NE). The fractionation was
performed on a normal phase RediSep 12 g column (Teledyne
Isco, Lincoln, NE) at a flow rate of 25 ml/min with a linear
gradient. The solvent system was composed of 10% acetic acid in
toluene as solvent A and 10% acetic acid in ethyl acetate as solvent
B. The % of solvent B increased from 0% to 45% within 10 min
with a fraction volume of 5 ml. Thirty fractions were collected
from the sample extracted in chloroform. The most active fraction
was evaporated, dissolved in methanol and fractionated by HPLC-
DAD using a 150 mm64.6 mm Luna C18 5 mm column
(Phenomenex, Torrance, CA) in a HPLC chromatograph
(Kontron, Milan, Italy). The flow rate was set to 1.5 ml/min. A
gradient of water with 0.1% acetic acid and acetonitrile was used
as mobile phase increasing from 10% to 40% acetonitrile in
18 min, then increasing to 90% within 10 min, maintained for
10 min, before returning to the initial proportions. The fraction-
ation was performed as follows: F1 (1–10 min), F2 (10–15 min), F3
(15–17 min), F4 (17–19 min), F5 (19–21 min), F6 (21–23 min), F7
(23–25 min), F8 (25–30 min), F9 (30–40 min) and F10 (40–
46 min).
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Trypacidin, monomethylsulochrin and questin were purified
from the crude extract by a two step semi-preparative HPLC. In
the first step, a 250 mm67.8 mm Modulo-Cart Strategy 5 mm
C18 column (Interchim, Montluc ¸on, France) was used under
isocratic conditions (32% (v/v) acetonitrile, 68% (v/v) 16.6 mM
acetic acid) with a flow rate of 4.5 ml/min. Samples enriched in
trypacidin and in monomethylsulochrin and questin were
obtained. In the second step, the mobile phase was methanol
and 16.6 mM acetic acid with a flow rate of 3.5 ml/min.
Trypacidin containing samples were chromatographed isocrati-
cally with 45% (v/v) methanol and the monomethylsulochrin and
questin containing samples at 50% (v/v) methanol. Purified
fractions were evaporated before being dissolved in methanol.
ThepurityofthecompoundswasconfirmedbyLC-MSandNMR
as described below. The concentration of the samples was measured
by reading the absorbance at 286 nm for trypacidin (e25uMeOH=23
400 M
21 cm
21) and questin (e25uMeOH=25 704M
21 cm
21)a n d




1H and two-dimensional nuclear magnetic resonance (2D-
NMR) spectra were generated using a Bruker Avance DRX-600
spectrometer (Bruker, Wissembourg, France) operating at
600.13 MHz in CDCl3 solution (70–200 mg sample/600 ml
solvent in a 5 mm NMR tube).
All measurements were obtained using a Bruker cryoprobe TXI
at 300 K with tetramethylsilane as reference standard.
To confirm the chemical structures, samples were analyzed
using
1H and 2D-NMR including gradient selection (gs)-
correlation spectroscopy (COSY), (gs)-heteronuclear single quan-
tum coherence (HSQC) and (gs)-heteronuclear multiple bonding
connectivity (HMBC).
13C chemical shifts were determined from the f1 projection of
HSQC and HMBC diagrams, because the low amount of product
(70 mg) precluded the direct measurement of a carbon spectrum.
The spectral data of the analysed compounds (questin,
monomethylsulochrin, trypacidin, fumiquinazoline C, tryptoqui-
valine F) are described in Figure S1.
Cell culture conditions
The human alveolar carcinoma cell line A549 was obtained
from the DSMZ-German Collection of Microorganisms and Cell
Cultures (Braunshweig, Germany). Cells were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) with added 10%
heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 IU/ml
penicillin and 100 mg/ml streptomycin at 37uC in a humidified
atmosphere with 5% CO2.
The human bronchial epithelial cells (HBEpC) were purchased
from Cell Application Inc. (San Diego, CA). HBEpC are primary
cells derived from normal human bronchi. They were cultured in
Bronchial Epithelial Cell Growth Medium provided by Cell
Application Inc. at 37uC in a humidified atmosphere with 5%
CO2.
Cell viability measurement: MTT assay
Cell viability was determined using the CellTiter 96H Non-
Radioactive Cell Proliferation Assay (Promega, Madison, WI).
The assay is based on the cellular conversion of a tetrazolium salt
(3,(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide) into
a formazan product by mitochondrial succinate dehydrogenase.
The formazan product is detected by absorbance at 570 nm. Cells
were plated into 96-well flat plates in 100 ml growth medium
(1610
4 cells/well for A549 and 2610
4 cells/well for HBEpC) and
cultured for 24 h. The cells were then exposed to toxins for either
24 h or 48 h. Negative and positive controls were obtained by
treating cells with respectively the solvent alone or with 10 mM
gliotoxin. Blanks were obtained with the absence of cells in the
wells. A 3,(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bro-
mide (MTT) solution (5.0 mg/ml) was added to the wells (15 ml/
well), and the plates incubated at 37uCi n5 %C O 2 for 4 h. The
absorbance (Abs) was measured in a microplate reader ‘Infinite
200’ (Tecan, Gro ¨dig/Salzburg, Austria) at 570 nm and 650 nm
(reference). The % viability was calculated as follow: (Abstoxin –
Absblank)/(Absnegative – Absblank) 6100%.
The toxin concentration needed to reduce cell viability by 50%
(IC50) was calculated using the software SigmaPlot (Systat
Software Inc., San Jose, CA).
Cell lysis measurement: LDH assay
Cell lysis was measured using the CytoTox 96H Non-
Radioactive Cytotoxicity Assay (Promega, Madison, WI). 1610
4
A549 cells/well were plated into 96-well round bottom plates in
100 ml growth medium for 24 h and then exposed to toxins for
another 24 h. Negative and positive controls were obtained by
treating cells with respectively the solvent alone or with 50 mM
gliotoxin. After centrifugation at 4506g for 5 min, 30 ml of cell
culture medium were collected and placed in a 96-well microtitre
plates. The cells were then treated with 70 ml 1.8% Triton X-100
for 30 min at 37uC to release the total amount of LDH and then
30 ml were collected and placed in another 96-well microtitre
plate. Fifty ml of the substrate solution were added and after thirty
min the reaction was stopped by adding 70 ml of 1N acetic acid.
Absorbance at 490 nm was recorded to measure formazan
production which correlated with the amount of LDH in the
wells. The ratio between the LDH released in the supernatant and
the total amount of LDH indicates the percentage of lysis triggered
by the toxin. The toxin concentration needed to cause 50% cell
lysis (IC50) was calculated using the software SigmaPlot (Systat
Software Inc., San Jose, CA).
Cell cycle and apoptosis assay
The cell cycle was investigated using DNA flow cytometry [27].
A549 or HBEpC cells (3610
5 cells/well) were seeded in 12-well
plates and incubated until reaching approximately 70% conflu-
ence. The cells were then exposed to different concentrations of
trypacidin (1, 10, 30, 50 mM) or gliotoxin 5 mM for 24 h. Cells
were harvested after trypsinization and centrifugation at 4506g for
6 min, washed with phosphate-buffered saline (PBS) and then
fixed in 75% (v/v) ethanol for 4 h at 220uC. The cells were
collected by centrifugation, washed twice with PBS and suspended
in 0.4 ml of a propidium iodide solution containing RNase (BD
Pharmingen, San Diego, CA) for 30 min at 37uC. Flow cytometry
was used to sort cells in G0/G1 phase (2 n DNA), S phase (between
2 n and 4 n DNA), G2/M phase (4 n DNA) and sub-G1 particles
(,2 n DNA). The stained cells were analysed using a flow
cytometer (Becton Dickinson FACSCalibur System, San Jose, CA)
and the data were calculated using Flowjo software (Tree Star,
Inc., Ashland, OR).
Measurement of the mitochondrial transmembrane
potential (DYm)
The mitochondrial transmembrane potential was assessed using
3,39-dihexyloxacarbocyanine iodide (DiOC6, Molecular Probes,
Madison, WI) whose accumulation on the inner surface of the
inner mitochondrial membrane is driven by DYm. After 2 h and
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harvested by centrifugation at 4506g for 6 min and incubated in
1 ml of cell suspension buffer (10 mM Hepes pH 7.4, 125 mM
NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1 mM MgCl2,1m M
CaCl2, 10 mM glucose) containing 50 nM DiOC6 for 20 min at
37uC. Carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone
40 mM (FCCP, Enzo Life Sciences, Ann Arbor, MI) was used as
positive control. The cells were then collected by centrifugation
and suspended in 0.3 ml PBS. DiOC6 fluorescence was recorded
using a flow cytometer (Becton Dickinson FACSCalibur System,
San Jose, CA) and the data were calculated using Flowjo software
(Tree Star, Inc., Ashland, OR).
Detection of reactive oxygen species (ROS) and reactive
nitrogen species (RNS)
A549 cells were treated with 10 mM and 50 mM trypacidin for
1, 2 and 24 h in the presence of oxidation-sensitive fluorescent
probes: 5 mM dihydroethidium (DHE, Molecular Probes, Madi-
son, WI) to detect superoxide anion (O2
N2), 10 mM dichlorodihy-
dro-fluorescein diacetate (H2DCF-DA, Molecular Probes, Madi-
son, WI) to detect H2O2 and 5 mM 4-amino-5-methylamino-29,79-
difluorofluorescein diacetate (DAF-FM, Molecular Probes, Madi-
son, WI) to detect NO. Pro-oxidants were used as positive controls:
100 mM menadione (Sigma-Aldrich, St. Louis, MO) for DHE and
H2DCF-DA, and 2.5 mM S-nitroso-N-acetylpenicillamine
(SNAP, Molecular Probes, Madison, WI) for DAF-FM. Dead
cells were stained by adding 300 ng/ml propidium iodide
(Molecular Probes, Madison, WI). Cells were harvested by
centrifugation and suspended in 0.3 ml PBS before analysis using
a flow cytometer (Becton Dickinson FACSCalibur System, San
Jose, CA). The data were calculated using Flowjo software (Tree
Star, Inc., Ashland, OR).
Results
The overall strategy of the current study is summarized in
figure 1:
In a first step, the spore borne metabolites were identified by
three independent experiments:
i) Comparison of secondary metabolites produced from con-
idiogenesis deficient Dbrla strain and from reverse mutant
Dbrla::brlA strain.
ii) Comparison of secondary metabolites produced when the
wild type strain is cultured under conidiogenesis inducing
conditions vs restrictive conditions.
iii) LC-MS analyses of conidia extract.
In a second step, the production and purification of the
identified spore borne metabolites were achieved from A. fumigatus
culture grown in the best conditions for sporulation. The purified
metabolites were analyzed for their toxic effects on A549 lung
cells.
Identification of spore borne metabolites from Aspergillus
fumigatus
In order to determine which mycotoxins are associated with
conidiogenesis, comparisons of HPLC-DAD and MS analyses of
culture extracts from conidiation-deficient DbrlA and conidiation-
restored DbrlA::brlA strains were made. In accordance with Coyle
et al. [26], the conidiating strain produced fumigaclavine B and
five other metabolites that were not detected in crude extracts of
the DbrlA mutant (Figure 2). The first eluted metabolite
(16.88 min) showed a typical fumiquinazoline/tryptoquivaline
UV spectrum and a base peak at m/z 403 in LC-MS positive
mode. After collision, the MS
2 peaks were observed at m/z 239
(100%), m/z 199 (90%), m/z 211 (60%), m/z 171 (%) and m/z 147
(10%). This metabolite was identified as tryptoquivaline F or J
(Figure 3A). The second eluted metabolite (17.57 min) had the
same UV spectrum but showed a base peak at m/z 444 in LC-MS
positive mode. The collision-induced dissociation MS-MS spec-
trum at m/z 444 led to a fragment at m/z 199 (100%), m/z 228
(80%), m/z 373 (60%) and m/z 171 (20%). This metabolite was
identified as fumiquinazoline C (Figure 3B). The compound eluted
in the third position (20.70 min) gave a UV spectrum character-
istic of trypacidin and showed a base peak at m/z 345 (Figure 3C).
The MS
2 peaks were observed at m/z 301 and m/z 313. The
following metabolite (21.79 min) had the UV spectra of mono-
methylsulochrin and showed a base peak at m/z 345 in LC-MS
negative mode (Figure 3D). Its MS
2 spectra displayed m/z 313
(100%) and m/z 181 (40%). Finally, the last compound
(22.34 min) gave a typical anthraquinone UV spectrum and
showed a base peak at m/z 283 in LC-MS negative mode. These
results strongly suggested that this product was questin (Figure 3E).
The identity of all five products was confirmed by NMR analyses
(Figure S1).
Meanwhile, in a second experiment, the wild type strain
(NRRL35693) was grown under condiogenesis repressive and
inducing conditions. Then, the extract from culture was analysed
by HPLC-DAD (Figure 4). As long as the fungus did not sporulate,
many compounds were specifically detected (pseurotins, fumagil-
lins, fumitremorgins, verruculogen and gliotoxin) but none of the
five products identified above. However, two days after con-
idiogenesis induction, chromatography analyses revealed the
presence of fumiquinazoline C, tryptoquivaline F, trypacidin,
questin and monomethylsulochrin. Although both experiments
showed that these five metabolites are associated to conidiation
their location on the conidia still remained to be proved.
Consequently, extracts of conidia from the other wild strain
(NRRL 35693) were also analyzed by LC-MS (Figure 5). All the
five metabolites, trypacidin, monomethylsulochrin, questin, tryp-
toquivaline F and fumiquinazoline C were detected in the conidial
extracts. These 5 compounds, moreover, were also detected by
LC-MS analysis in all of the 17 A. fumigatus culture extracts
mentioned in Table S1.
Figure 1. Overall strategy to assess the toxicity of spore borne
metabolites.
doi:10.1371/journal.pone.0029906.g001
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Fractions obtained from chromatoflash and containing the 5
main toxins borne by conidia, were tested for their cytotoxicity to
A549 cells using the MTT assay. The composition of each
fraction regarding other secondary metabolites produced by
Aspergillus fumigatus was determined by LC-MS analysis (Table 1).
In addition to the airborne metabolites, fumagillin, verruculogen,
helvolic acid, fumigaclavine A were also detected in those
fractions. The most toxic fractions (F14, F16, F18) contained all
metabolites. It is noteworthy, however, that the elution pattern of
trypacidin, fumagillin and fumigaclavine A shared a profile
similar to that of the toxicity of the fractions. The significance of
the two latter compounds, however, could be discounted since
100 mM fumagillin or fumigaclavine A did not trigger any
significant loss of viability (106.065.6% and 107.266.0% cell
viability respectively). Since F16 fraction displayed the highest
toxic activity compared to the other fractions whatever the tested
dilution (Figure S2), it was chosen to be fractionated on reverse-
phase-HPLC (Figure S3). The measurement of the toxicity and
the metabolite content of the resulting sub-fractions showed that
the fractions containing tryptoquivaline F and fumiquinazoline C
had very low toxicity (Table 2). The most toxic fraction F6,
conversely matched the peaks of trypacidin, monomethylsulo-
chrin and questin but also fumagillin. When tested alone,
however, fumagillin and verruculogen showed no detectable
toxicity even at the high concentration of 100 mMt h e r e b y
confirming that the toxicity of F6 and F7 was due to the presence
of trypacidin, monomethylsulochrin and questin. It is noteworthy
that these three metabolites are components of the pathway
leading to trypacidin synthesis (Figure 6). The toxic activities
induced by fractions F8, F9 and F10 were correlated to the
presence of an unknown compound which does not absorb from
200 to 600 nm but displayed a base peak at m/z 453 in LC-MS
positive mode.
Toxicity of trypacidin and its intermediate metabolites
These three metabolites were purified by RP-HPLC and their
chemical structures verified by NMR. Their toxicity was
compared with emodin and sulochrin, two other commercially
available intermediate metabolites of the trypacidin pathway,
using the MTT and LDH assays (Figure 7). The results show that
50 mM trypacidin reduced cell viability by nearly 100% and
triggered 85% cell lysis while the other metabolites showed only
slight or no toxicity at this concentration. Even at 100 mM,
sulochrin and monomethylsulochrin still showed no effects in
either assay whereas both emodin and questin had a significant
(p,0.001) but minor effect on the cell viability (6464% and
4467% inhibition, respectively) and little effect on cell lysis. These
results indicated that trypacidin was much more toxic than its
precursors and is the most toxic compound among the five tested
metabolites.
Figure 2. HPLC-chromatograms at 270 nm of A. fumigatus extracts. A) conidiation-deficient A. fumigatus strain (DbrlA) and B) conidiation-
restored strain (DbrlA::brlA). The fungi were cultured at 25uC on PDA for 13 days in the dark as described in the Materials and Methods.
doi:10.1371/journal.pone.0029906.g002
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The dose-effect study of trypacidin on cell viability and cell lysis
was determined on A549 cells after 24 h exposure in culture. The
results show a dose-dependence at concentrations ranging from 0.5
to50 mM(FigureS4).TrypacidingavethesameIC50forcellviability
and cell lysis, respectively 7.462.0 mM( n = 5 )a n d7 . 4 62.4 mM
(n=5) indicating that at the same concentration the loss of the cell
viability observed after 24 h exposure was effecting cell lysis.
When the cells were exposed to 50 mM trypacidin for only 1 or
2 h, the cell viability measured after 24 h of culture was the same
as that measured when the cells were exposed to the same
concentration of trypacidin for 24 h (Table 3). These results show
that trypacidin rapidly induced an irreversible process leading to
the cell death within 24 h.
Production of ROS and RNS following trypacidin
exposure
To determine whether A549 cells produced ROS and RNS in
response to trypacidin exposure, we used fluorescent probes to
measure the formation of O2
N2,H 2O2 and NO following short
(1 h, 2 h) and long (24 h) exposures to 10 mM and 50 mM of the
toxin (Figure 8). Production of H2O2 and NO was observed as
soon as one hour exposure while, in contrast, no detectable
formation of O2
N2 was observed within the same time period.
After 24 h exposure, 10 mM trypacidin induced H2O2 and NO
production in about 50% of the cell population while 50 mM
trypacidin induced production of H2O2, NO but also O2
N2 in the
whole cell population. In that latter condition, most of the NO and
H2O2 producing cells were dead (80% and 70% respectively) as
shown by propidium iodide staining (Figure 9). It can be
Figure 4. HPLC-DAD chromatograms from Aspergillus fumigatus (NRRL 35693) when grown in condition repressing (A) and inducing
(B) conidiogenesis. The NRRL 35693 strain was cultured on Czapek-Glucose medium, at 25uC for 13 days in the dark under shaking (180 r.p.m.).
Every day, the culture (mycelia and medium) was removed from the flask and placed in a new sterile flask in order to avoid that mycelium adhering to
glass and sporulating in contact with the air. After 13 days, culture medium was harvested and analyzed by DAD-HPLC. The remaining pellets of
mycelia were exposed to daylight without medium at 25uC in order to induce conidiogenesis. The secondary metabolites were extracted from pellets
as described in the Materials and Methods.
doi:10.1371/journal.pone.0029906.g004
Figure 3. Identification and structures of the 5 major compounds isolated from A. fumigatus conidia extracts. MS spectra (left) and UV-
Vis spectra (right). A) tryptoquivaline F/J, B) fumiquinazoline C, C) trypacidin, D) monomethylsulochrin, E) questin.
doi:10.1371/journal.pone.0029906.g003
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early cell death of a minor part of the cell population and that the
later cell death appeared after oxidative injury.
Taken together, those results suggested that trypacidin induced
an oxidative stress in the cells which was strongly implicated in the
death process.
Effect of trypacidin on the cell cycle and apoptosis
In order to determine if trypacidin was able to arrest the cell
cycle or to induce apoptosis, flow cytometry was used to examine
any modification of the G0/G1, S, G2/M phase ratio or
appearance of a sub-G1 fraction (Figure 10), which is typical of
apoptotic bodies. The experiment was performed with A549
alveolar lung cells and with bronchial epithelial cells (HBEpC), two
types of respiratory tract cells. Indeed, since A549 is a cancer cell
line, which could result in impairment of the apoptotic pathway, so
it was important to obtain results with primary lung cells. The
toxicity of trypacidin against HBEpC cells was previously
determined with the MTT assay under the same conditions used
for the A549 line. The IC50 obtained (9.262.0 mM; n=6) was not
significantly different from the IC50 obtained with the A549 cells.
Figure 10 shows that at concentrations from 1 mMt o5 0mM,
trypacidin did not alter the cell cycle and did not induce sub-G1
particles in either cell type suggesting that the toxin did not trigger
the formation of apoptotic bodies. This latter result was confirmed
by the measurement of the mitochondrial membrane potential
(DYm) in the A549 cells (Figure 11). A reduction in the DYm is an
early event in apoptosis caused by the leakage of protons from the
intermembrane space of the mitochondria due to the formation of
pores in the mitochondrial membrane [28]. After 2 h or 24 h
exposure to 10 or 50 mM trypacidin, the A549 cells did not show
any loss of mitochondrial potential.
These results showed that trypacidin neither arrested the cell
cycle nor induced apoptosis in contrast to the effects of 5 mM
gliotoxin which induced 23.366.0% and 29.461.5% sub-G1
particles in A549 and HBEpC cell populations respectively.
Discussion
Since the identification of trypacidin and the demonstration of
its anti-protozoal properties against Trypanosoma cruzi and Toxo-
plasma gondii in 1963 [22], no study had been performed regarding
its toxicity to mammalian cells. This is the first time that the
toxicity of this secondary metabolite has been demonstrated,
which means it can be considered to be a mycotoxin.
A large number of secondary metabolites are potentially
produced by Aspergillus fumigatus, depending on the growth
conditions of the fungus. Only a limited number are airborne,
however, carried by the spores. We could identify metabolites that
were produced when A. fumigatus sporulated but were not detected
Figure 5. Representative HPLC-DAD and LC-MS chromatograms of conidial extract from A. fumigatus. (A) total scan photo diode array
(PDA) chromatogram. Chromatogram of the ion at (B) m/z 403 in positive ionization mode (tryptoquivaline F), (C) m/z 444 in positive ionization mode
(fumiquinazoline C), (D) m/z 345 in positive ionization mode (trypacidin), (E) m/z 345 in negative ionization mode (monomethylsulochrin), (F) m/z 283
in negative ionization mode (questin).
doi:10.1371/journal.pone.0029906.g005
Table 1. Comparison of LC-MS analysis of the fractions
obtained from flash chromatography and their effect on the
A549 cell viability.
Fraction
control F12 F14 F16 F18 F19 F20 F30
Metabolites Relative LC-MS peak intensity
Fumagillin 58.2 100 60.2 41.8 nd nd nd
Trypacidin 27.2 100 100 81.7 24.5 70.0 nd
Fumigaclavine A nd 46.3 100 47.2 26.0 nd nd
Helvolic acid nd 56.5 83.1 100 77.2 nd nd
Monomethylsulochrin nd 11.1 89.2 100 92.3 98.5 nd
Questin 1.3 5.2 57.4 100 81.8 100 1.7
Verruculogen 12.6 53.6 53.6 88.9 97.5 100 11.5
Fumiquinazoline C nd 18.2 49.3 48.5 61.3 100 nd
Tryptoquivaline F 9.8 5.7 23.8 29.5 44.0 100 43.5
cell viability (%) 95.2 34.2 2.1 2.8 0.2 34.3 22.6 88.6
Fractionation of bulk culture extracts using flash chromatography. To measure
their toxicity, each 5 ml fraction was dried and solubilised in 500 ml in PBS-
DMSO 40% and then diluted 10 fold in PBS-DMSO 12%. The final concentration
of DMSO in the assay medium was 1.2%. The cells were exposed for 24 h before
measuring the cell viability as described in the Materials and Methods. The
effect of 1.2% DMSO was used as negative control. For each metabolite, the
figures are arbitrary units indicating its elution profile with 100 corresponding
to the maximum normalized level measured by the LC-MS sensor. nd means not
detectable.
doi:10.1371/journal.pone.0029906.t001
Table 2. Comparison of LC-MS analysis of the F16 sub-
fractions obtained from the RP-HPLC and their effect on the
A549 cell viability.
Fraction
c o n t r o l F 3F 4F 5F 6F 7F 8F 9F 1 0
Metabolites Relative LC-MS peak intensity
Tryptoquivaline F nd 42.0 100 6.7 nd nd nd nd
Fumiquinazoline C nd 31.3 100 8.3 4.2 nd nd nd
Fumagillin nd 97.5 100 93.1 nd nd nd
Trypacidin nd 100 8.8 3.0 nd nd
Monomethylsulochrin nd 100 40.9 2.3 nd nd
Questin nd 100 54.7 1.6 nd nd
Verruculogen nd nd 100 58.9 nd nd
Helvolic acid nd nd nd 100 nd nd
Fumitremorgin B nd nd nd 100 nd nd
Emodin nd nd nd nd nd nd
Fumigaclavine A nd nd nd nd nd nd
Unknown (m/z 453)* nd nd nd 60.3 100 48.1
cell viability (%) 92.5 80.7 79.0 77.2 35.5 48.7 47.0 47.1 70.4
Sub-fractionation of F16 fraction using RP-HPLC. F3 to F7 were each collected
for 2 min, F8 for 5 min, F9 for 10 min and F10 for 6 min. Each fraction was
evaporated and the dried material was dissolved in 50 ml PBS-DMSO 12%. The
final concentration of DMSO in the assay medium was 1.2%. The cell viability
was measured by the MTT assay described in the Materials and Methods after
exposing A549 cells to the metabolites for 48 h. The effect of 1.2% DMSO was
used as negative control. For each metabolite, the figures are arbitrary units
indicating its elution profile, 100 corresponding to the maximum normalized
level measured by the LC-MS sensor. nd means not detectable.
*m/z in positive mode electrospray ionization.
doi:10.1371/journal.pone.0029906.t002
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fumigaclavines production in DbrlA strain is consistent with de
BrlAp dependence of genes involved in biosynthesis of these
secondary metabolites as shown previously in a transcriptome
study [29]. Likewise, the absence of fumiquinazoline C production
in DbrlA strain is consistent with the down-regulation of two genes
(Afu6g12050 and Afu6g12070) essential for its synthesis [30,31].
By contrast, the fumitremorgens cluster [32] was reported to be
suppressed by BrlAp, explaining the strong production of
fumitremorgins and verruculogen in DbrlA strain. Since the genes
cluster involved in trypacidin biosynthesis has not been yet
characterized it was not possible to compare our metabolome data
with the transcriptome data previously published [29].
Fischer et al. reported that trypacidin and a tryptoquivaline
were both found in A. fumigatus spore extracts and in bioaerosols
from compost [21]. Doubts still remained, however, about the
effective production of tryptoquivalines by A. fumigatus. A previous
report [33] had postulated that fumiquinazolines had been
misidentified as tryptoquivalines in Fischer’s study since trypto-
quivalines and fumiquinazolines share similar UV spectra [15].
This was also seen in other previous studies [34,35,36].
Tryptoquivaline J was, however, isolated recently from an A.
fumigatus strain by Afiyatullov [37]. The current results confirm the
effective synthesis of tryptoquivalines by this species. They also
confirm that trypacidin and tryptoquivaline F/J are borne by the
spores and that 3 other metabolites, monomethylsulochrin, questin
and fumiquinazoline C are also present in the spores of A.
fumigatus. The toxicity of those 5 compounds on airway tissues,
however, had not been studied until now.
Trypacidin was found to be the most toxic metabolite borne by
the spores in the current study. The fungal precursor metabolites
of trypacidin biosynthesis had low toxicity compared with
trypacidin. Sulochrin and monomethylsulochrin did not cause
cell lysis or reduce cell viability whereas the two anthraquinone
derivatives, emodin and questin, reduced only cell viability at
respectively 100 mM and 50 mM. These results are partially in
agreement with a previous report showing that sulochrin and
questin did not trigger any toxic effects on A549 cells at 150 mM
using the same MTT assay [38]. It should be noted, however, that
these authors used a different process of purification to obtain
questin. This could mean that other compounds present in the
questin preparation could overestimate the calculated 150 mM
concentration used in the MTT assay.
The toxicity of trypacidin was assayed with A549 alveolar lung
cells and human bronchial epithelial cells which are representative
of the upper and lower airway respiratory tract, respectively.
Toxicity was dose-dependent with both cell types with a 50%
Figure 7. Toxicity effect of the trypacidin pathway metabolites
on A549 cells. Cell viability and cell lysis were measured using
respectively MTT and LDH assay. The cells were exposed for 24 h in
culture conditions to each metabolite before measuring cell viability
and cell lysis as described in the Materials and Methods. The graph
shows the mean values of three independent experiments, excepted for
trypacidin for which five experiments were carried out. Negative and
positive control corresponds respectively to 1% DMSO and gliotoxin
(10 mM for MTT assay and 50 mM for LDH assay). Trypacidin was tested
at 50 mM and the other metabolites at 50 and 100 mM. Significant
difference from the negative control was analysed with the t-test (* for
p,0.05; ** for p,0.001).
doi:10.1371/journal.pone.0029906.g007
Figure 6. Outline biosynthesic pathway for trypacidin.
doi:10.1371/journal.pone.0029906.g006
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cell death within the first hour of exposure leading to cell necrosis
within 24 h as shown by the release of the cytosolic enzyme LDH.
Other mycotoxins such as gliotoxin, aflatoxin B1 produced by
the Aspergillus genus and deoxynivalenol, a trichothecene myco-
toxin produced by several Fusarium species, were previously
reported to trigger ROS formation within 1 h of exposure in
different types of cells. These included a porcine renal proximal
tubular cell line [39], hepatic stellate cells [40], hepatocytes [41],
hepatoma cells HepG2 [42], and colon HT29 cells [43].
ROS and RNS are known to oxidize cell constituents such as
DNA, proteins and lipids, leading to cell damage or death.
It was thus of interest to assess whether trypacidin would induce
the formation of ROS and RNS in A549 cells. Our results show
clearly that trypacidin induces hydrogen peroxide (H2O2) and
nitric oxide (NO) within the first hour of exposure and that their
accumulation after 24 h exposure is correlated with cell lysis as
shown by the LDH release. It can be noted that O2
N2 accumulated
in A549 cells only when levels of NO and H2O2 dramatically
increased. H2O2 is produced from O2
N2 through superoxide
dismutase (SOD) activity. The O2
N2 accumulation could be due to
the inhibition of SOD activity by an exceeding level of H2O2.
In the current study, trypacidin did not induce either an arrest
of the cell cycle or apoptotic bodies in lung alveolar and bronchial
epithelial cells. It was also observed that trypacidin did not induce
a collapse of the mitochondrial transmembrane potential of A549
cells. This confirms that the apoptosis machinery was not initiated
by the trypacidin toxicity.
The unchanged mitochondrial transmembrane potential, how-
ever, suggests an inhibition of the electron transport chain without
pore formation. These results are consistent with a previous study
Table 3. Inhibition of A549 cell viability by trypacidin.
Trypacidin mM
10 50




A549 cells were exposed for 1 h and 2 h with 10 mM and 50 mM trypacidin, then
the medium containing trypacidin was replaced by fresh medium and cell
viability was measured 24 h later using MTT assay. Cells were also exposed to
trypacidin for 24 h before the MTT assay.
doi:10.1371/journal.pone.0029906.t003
Figure 8. Flow cytometry analysis of ROS and RNS production. A549 cells were seeded at 3610
4 cells/cm
2 and cultured for 24 h. Then, cells
were exposed to trypacidin (green area) 10 mM and 50 mM or DMSO 1% (red line) for 1 h, 2 h and 24 h. H2O2 production was assessed using H2-DCF-
DA, O
2N2 using DHE, NO using DAF-FM. Menadione was used as control for H2-DCF-DA and DHE, SNAP for DAF-FM (blue line). Peaks are
representative of three independent experiments.
doi:10.1371/journal.pone.0029906.g008
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membrane blebbing and apoptotic bodies in A549 cells and that
the cells died from necrosis [44]. It has been shown, furthermore,
that conidia from A. fumigatus isolated from humans, birds and the
environment were able to inhibit apoptosis induced in A549 cells
and 16HBE bronchial epithelial cells [45].
The current study shows that conidia from A. fumigatus mainly
carry 5 secondary metabolites but only trypacidin is highly toxic to
lung cells. However, the analysis of eight Aspergillus genomes, and
particularly that of A. fumigatus genome [12,13], revealed a number
of PKS and NRPS genes much greater than the number predicted
known secondary metabolites. Given the existence of genes
Figure 9. Flow cytometry analysis of H2O2 and NO related to PI staining. A549 cells were seeded at 3610
4 cells/cm
2 and cultured for 24 h.
Then, cells were exposed to trypacidin 50 mM or DMSO 1% for 2 h and 24 h. H2O2 and NO production were measured using respectively H2-DCF-DA,
and DAF-FM. IP was used to stain dead cells. Dot-blots are representative of three independent experiments.
doi:10.1371/journal.pone.0029906.g009
Figure 10. Flow cytometry analysis of the cell cycle. A549 and HBEpC were exposed to 1, 10, 30 and 50 mM trypacidin for 24 h in culture
conditions. In the negative control (0 mM trypacidin), cells were exposed to 1% DMSO. Gliotoxin 5 mM was used as positive control to induce sub-G1
particles. The cells were then harvested and analysed for cell cycle as described in the Materials and Methods. The figure shows mean values for 3
independent experiments.
doi:10.1371/journal.pone.0029906.g010
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results do not exclude the possibility of cryptic spore-born products
not activated in our culture conditions, but induced in field
conditions.
Accumulation of spores in cavities of the alveoli (about 4 nl)
could lead to pneumocytes being exposed to a toxic level of
trypacidin. In vivo studies have confirmed that other airborne spore
mycotoxins can induce pulmonary inflammation. Low doses
(4610
25 mole/kg lung wt) of atranone C, brevianamide,
cladosporin, mycophenolic acid, neoechinulin and sterigmatocys-
tin induced pulmonary inflammation when applied intratracheally
in mice [48]. It was also shown that instillation into mice of a low
number of spores from Stachybotrys chartarum (30 spores/g body
weight) is cytotoxic for lung cells with LDH being released in the
bronchoalveolar lavage fluid [49].
Additional work has to be performed in order to know whether
trypacidin could similarly induce lung cell necrosis in vivo.
Supporting Information
Figure S1 NMR spectrum data of questin, monomethyl-
sulochrin, trypacidin, fumiquinazoline C, tryptoquiva-
line F.
1H and two-dimensional nuclear magnetic resonance (2D-
NMR) spectra were generated using a Bruker Avance DRX-600
spectrometer operating at 600.13 MHz in CDCl3 solution as
described in Materials and Methods.
(DOC)
Figure S2 Toxicity of fractions issued from flash
chromatography. The toxic effect of fractions F12, F14, F16,
F18, F19, F20 were measured at four different dilutions in PBS-
DMSO 12%: 1/10, 1/50, 1/100, 1/500. Ten ml of each fraction
were added to wells containing 100 ml of culture medium. The
cells were exposed for 24 h before measuring the cell viability
using the MTT assay as described in the Materials and Methods.
(PDF)
Figure S3 Sub-fractionation of F16 fraction using RP-
HPLC. F16 fraction was evaporated, dissolved in methanol and
fractionated using RP-HPLC. Ten fractions were collected as
follows: F1 (1–10 min), F2 (10–15 min), F3 (15–17 min), F4 (17–
19 min), F5 (19–21 min), F6 (21–23 min), F7 (23–25 min), F8 (25–
30 min), F9 (30–40 min) and F10 (40–46 min). Each subfraction
was analysed by HPLC-DAD and LC-MS. A) HPLC chromato-
gram at 270 nm of fraction F16. B) PDA total scan [200–600 nm]
chromatogram of subfractions 5–10.
(PDF)
Figure S4 Dose dependent effect of trypacidin on cell
viability and cell lysis. 1610
4 A549 cells were cultured for
24 h in 96-well plates and then exposed to trypacidin for 24 h.
Cell viability and cell lysis were measured as described in Materials
and Methods using the MTT and LDH assays. The figure is
representative of 5 independent experiments. The toxin concen-
tration triggering 50% toxic effect (IC50) was calculated using the
software SigmaPlot.
(PDF)
Table S1 Aspergillus fumigatus strains studied.
(DOC)
Acknowledgments
We thank L. Guzylack and L. Huc-Lemarie for their kind advice and
technical assistance on this project. We thank also J.P. Latge ´ for providing
the cultures of most of the A. fumigatus strains studied and D. Panaccione for
the generous gift of DbrlA and DbrlA::brlA strains as well.
We thank Pr. Trevor K. Smith and Dr. John Woodley for their
corrections of the original manuscript.
Author Contributions
Conceived and designed the experiments: TG OP. Performed the
experiments: TG XW JSDS AF ST CC MPA NL OP. Analyzed the
data: TG CC NL OP. Contributed reagents/materials/analysis tools: TG
XW AF CC OP. Wrote the paper: TG CC IPO OP.
References
1. Samson RA, Flannigan B, Flannigan ME, Verhoeff AP, Adan OCG, et al.
(1994) Health implications of fungi in indoor air environments. Air quality
monographs, vol. 2. Elsevier Science B.V. pp 531–538.
2. Zielinska-Jankiewicz K, Kozajda A,P i o t r o w s k aM ,S z a d k o w s k a - S t a n c z y k
I (2008) Microbiological contamination with moulds in work environment
in libraries and archive storage facilities. Ann Agric Environ Med 15: 71–
78.
3. Matysik S, Herbarth O, Mueller A (2008) Determination of volatile metabolites
originating from mould growth on wall paper and synthetic media. J Microbiol
Methods 75: 182–187.
4. Eduard W (2009) Fungal spores: a critical review of the toxicological and
epidemiological evidence as a basis for occupational exposure limit setting. Crit
Rev Toxicol 39: 799–864.
5. Araujo R, Amorim A, Gusmao L (2010) Genetic diversity of Aspergillus fumigatus
in indoor hospital environments. Med Mycol 48: 832–838.
6. Karvala K, Nordman H, Luukkonen R, Nykyri E, Lappalainen S, et al. (2008)
Occupational rhinitis in damp and moldy workplaces. Am J Rhinol 22:
457–462.
7. Latge JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:
310–350.
8. Arendrup MC, O’driscoll BR, Petersen E, Denning DW (2006) Acute
pulmonary aspergillosis in immunocompetent subjects after exposure to bark
chippings. Scand J Infect Dis 38: 945–949.
9. Batard E, Renaudin K, Morin O, Desjars P, Germaud P (2003) Fatal acute
granulomatous pulmonary aspergillosis in a healthy subject after inhalation of
vegetal dust. Eur J Clin Microbiol Infect Dis 22: 357–359.
10. Russell K, Broadbridge C, Murray S, Waghorn D, Mahoney A (2008)
Gardening can seriously damage your health. Lancet 371: 2056.
11. Dagenais, TR, Keller NP (2009) Pathogenesis of Aspergillus fumigatus in Invasive
Aspergillosis. Clin Microbiol Rev 22: 447–465.
Figure 11. Assessment of DYm. A549 cells were exposed 2 h or
24 h to 10 mM (green line) and 50 mM (blue line) trypacidin or with
solely 1% DMSO as negative control (red line). After treatment, cells
were stained with DiOC6 for 20 min. at 37uC. Cells incubated with
40 mM FCCP were used as positive control (brown line). The figure is
representative of 3 independent experiments.
doi:10.1371/journal.pone.0029906.g011
Trypacidin, an A. fumigatus Spore-Borne Mycotoxin
PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e2990612. Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, et al. (2005)
Genomic sequence of the pathogenic and allergenic filamentous fungus
Aspergillus fumigatus. Nature 438: 1151–1156.
13. Perrin RM, Fedorova ND, Bok JW, Cramer RA, Wortman JR, et al. (2007)
Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA.
PLoS Pathog 3: 508–517.
14. Khaldi N, Seifuddin FT, Turner G, Haft D, Nierman WC, et al. (2010)
SMURF: Genomic mapping of fungal secondary metabolite clusters. Fungal
Genet Biol 47: 736–741.
15. Frisvad JC, Rank C, Nielsen KF, Larsen TO (2009) Metabolomics of Aspergillus
fumigatus. Med Mycol 47: S53–71.
16. Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, et al. (2005)
Detection of gliotoxin in experimental and human aspergillosis. Infect Immun
73: 635–637.
17. Kwon-Chung KJ, Sugui JA (2009) What do we know about the role of gliotoxin
in the pathobiology of Aspergillus fumigatus? Med Mycol 47: S97–103.
18. Mitchell CG, Slight J, Donaldson K (1997) Diffusible component from the spore
surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative
burst is distinct from gliotoxin and other hyphal toxins. Thorax 52: 796–801.
19. Panaccione DG, Coyle CM (2005) Abundant respirable ergot alkaloids from the
common airborne fungus Aspergillus fumigatus. Appl Environ Microbiol 71:
3106–3111.
20. Fischer G, Mu ¨ller T, Schwalbe R, Ostrowski R, Dott W (2000) Species-specific
profiles of mycotoxins produced in cultures and associated with conidia of
airborne fungi derived from biowaste. Int J Hyg Environ Health 203: 105–116.
21. Fischer G, Mu ¨ller T, Ostrowski R, Dott W (1999) Mycotoxins of Aspergillus
fumigatus in pure culture and in native bioaerosols from compost facilities.
Chemosphere 38: 1745–1755.
22. Balan J, Ebringer L, Nemec P, Kovacs S, Dobias J (1963) Antiprotozoal
antibiotics. Isolation and characterization of trypacidin, a new antibiotic, active
against trypanosoma cruzi and toxoplasma gondii. J Antibiot 16: 157–160.
23. Turner WB (1965) The production of trypacidin and monomethylsulochrin by
Aspergillus fumigatus. J Chem Soc Perkin 1: 6658–6659.
24. Balan J, Kjaera A, Kovacs S, Shapiro RH (1965) The structure of trypacidin.
Acta Chem Scand 19: 528–530.
25. Khoufache K, Puel O, Loiseau N, Delaforge M, Rivollet, et al. (2007)
Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies
the electrophysiological properties of human nasal epithelial cells. BMC
Microbiol 7: 5.
26. Coyle CM, Kenaley SC, Rittenour WR, Panaccione DG (2007) Association of
ergot alkaloids with conidiation in Aspergillus fumigatus. Mycologia 99: 804–811.
27. Rabinovitch PS (1994) DNA content histogram and cell-cycle analysis. Methods
Cell Biol 41: 263–296.
28. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:
1309–1312.
29. Twumasi-Boateng K, Yu Y, Chen D, Gravelat FN, Nierman WC, et al. (2009)
Transcriptional profiling identifies a role for BrlA in the response to nitrogen
depletion and for StuA in the regulation of secondary metabolite clusters in
Aspergillus fumigatus. Eukaryot Cell 8: 104–115.
30. Ames BD, Haynes SW, Gao X, Evans BS, Kelleher NL, et al. (2011) Complexity
Generation in Fungal Peptidyl Alkaloid Biosynthesis: Oxidation of Fumiquina-
zoline A to the Heptacyclic Hemiaminal Fumiquinazoline C by the
Flavoenzyme Af12070 from Aspergillus fumigatus. Biochemistry 50: 8756–8769.
31. Ames BD, Liu X, Walsh CT (2010) Enzymatic processing of fumiquinazoline F:
a tandem oxidative-acylation strategy for the generation of multicyclic scaffolds
in fungal indole alkaloid biosynthesis. Biochemistry 49: 8564–8576.
32. Maiya S, Grundmann A, Li SM, Turner G (2006) The fumitremorgin gene
cluster of Aspergillus fumigatus: identification of a gene encoding brevianamide
F synthetase. Chembiochem 7: 1062–1069.
33. Larsen TO, Smedsgaard J, Nielsen KF, Hansen MAE, Samson RA, et al. (2007)
Production of mycotoxins by Aspergillus lentulus and other medically important
and closely related species in section Fumigati. Med Mycol 45: 225–232.
34. Geiser DM, Frisvad JC, Taylor JW (1998) Evolutionary Relationships in
Aspergillus Section Fumigati Inferred from Partial b-Tubulin and Hydrophobin
DNA Sequences. Mycologia 90: 831–845.
35. Hong SB, Go SJ, Shin HD, Frisvad JC, Samson RA (2005) Polyphasic taxonomy
of Aspergillus fumigatus and related species. Mycologia 97: 1316–1329.
36. Tepsic K, Gunde-Cimerman N, Frisvad JC (1997) Growth and mycotoxin
production by Aspergillus fumigatus strains isolated from a saltern. FEMS
Microbiol Lett 157: 9–12.
37. Afiyatullov SS, Kalinovskii AI, Pivkin MV, Dmitrenok PS, Kuznetsova TA
(2004) Fumitremorgins from the marine isolate of the fungus Aspergillus fumigatus.
Chem Nat Comp 40: 615–619.
38. Chomcheon P, Wiyakrutta S, Sriubolmas N, Ngamrojanavanich N, Mahidol C,
et al. (2009) Metabolites from the endophytic mitosporic Dothideomycete sp.
LRUB20. Phytochemistry 70: 121–127.
39. Zhou X, Zhao A, Goping G, Hirszel P (2000) Gliotoxin-induced cytotoxicity
proceeds via apoptosis and is mediated by caspases and reactive oxygen species
in LLC-PK1 cells. Toxicol Sci 54: 194–202.
40. Kweon Y-O, Paik Y-H, Schnabl B, Qian T, Lemasters JJ, et al. (2003) Gliotoxin-
mediated apoptosis of activated human hepatic stellate cells. J Hepatol 39:
38–46.
41. Shen HM, Shi C-Y, Shen Y, Ong CN (1996) Detection of elevated reactive
oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free
Radical Bio Med 21: 139–146.
42. Zhang L, Zhang J, Hu C, Cao J, Zhou X, et al. (2009) Efficient activation of p53
pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2
interaction. Anticancer Drugs 20: 416–424.
43. Krishnaswamy R, Devaraj SN, Padma VV (2010) Lutein protects HT29 cells
against deoxynivalenol-induced oxidative stress and apoptosis: prevention of NF-
kB nuclear localization and down regulation of NF-kB and cyclo-oxygenase–2
expression. Free Radical Bio Med 49: 50–60.
44. Daly P, Verhaegen S, Clynes M, Kavanagh K (1999) Culture filtrates of
Aspergillus fumigatus induce different modes of cell death in human cancer cell
lines. Mycopathologia 146: 67–74.
45. Fe ´me ´nia F, Huet D, Lair-Fulleringer S, Wagner MC, Sarfati J, et al. (2009)
Effects of conidia of various Aspergillus species on apoptosis of human
pneumocytes and bronchial epithelial cells. Mycopathologia 167: 249–262.
46. Hertweck C (2009) Hidden biosynthetic treasures brought to light. Nat Chem
Biol 5: 450–452.
47. Brakhage AA, Schroeckh V (2011) Fungal secondary metabolites - strategies to
activate silent gene clusters. Fungal Genet Biol 48: 15–22.
48. Miller JD, Sun M, Gilyan A, Roy J, TG Rand (2010) Inflammation-associated
gene transcription and expression in mouse lungs induced by low molecular
weight compounds from fungi from the built environment. Chem-Biol Interact
183: 113–124.
49. Flemming J, Hudson B, Rand TG (2004) Comparison of inflammatory and
cytotoxic lung responses in mice after intratracheal exposure to spores of two
different Stachybotrys chartarum strains. Toxicol Sci 78: 267–275.
Trypacidin, an A. fumigatus Spore-Borne Mycotoxin
PLoS ONE | www.plosone.org 14 February 2012 | Volume 7 | Issue 2 | e29906